Grifols (GRFS) Cash & Current Investments (2010 - 2025)

Grifols (GRFS) reported Cash & Current Investments of $965.0 million for Q4 2025, down 8.41% on a YoY basis from $1.1 billion in Q4 2024, and down 8.41% quarter-over-quarter from $1.1 billion in Q4 2024.

Grifols (GRFS) Cash & Current Investments (2010 - 2025) Analysis & Trends

Grifols has reported Cash & Current Investments for 16 years, with the latest figure at $965.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash & Current Investments fell 8.41% year-over-year to $965.0 million; the trailing twelve-month figure through Dec 2025 stood at $965.0 million (down 8.41% YoY), and the FY2025 full-year result was $965.0 million, down 8.41% from the prior year.
  • Cash & Current Investments for Q4 2025 stood at $965.0 million, down from $1.1 billion in the prior quarter.
  • The five-year high for Cash & Current Investments was $5.4 billion in Q4 2021, with the low at $594.6 million in Q4 2023.
  • Historically, Cash & Current Investments has averaged $1.7 billion across 5 years, with a median of $965.0 million in 2025.
  • Annual changes were most pronounced in 2021 — Cash & Current Investments surged 678.94% — and 2022, when it tumbled 88.77%.
  • Grifols' Cash & Current Investments stood at $5.4 billion in 2021, then plunged by 88.77% to $604.7 million in 2022, then decreased by 1.66% to $594.6 million in 2023, then soared by 77.2% to $1.1 billion in 2024, then declined by 8.41% to $965.0 million in 2025.
  • The last three Cash & Current Investments figures came in at $965.0 million (Q4 2025), $1.1 billion (Q4 2024), and $594.6 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 4.38 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 5.28 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 22.05 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 9.39 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 5.70 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 12.04 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 7.64 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 13.08 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 10.49 Bn
10 Grifols 6.05 Bn 5.09 Bn - 964.99 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 964.99 Mn
Dec 31, 2024 1.05 Bn
Dec 31, 2023 594.61 Mn
Dec 31, 2022 604.66 Mn
Dec 31, 2021 5.38 Bn
Dec 31, 2020 691.11 Mn
Sep 30, 2020 1.22 Bn
Mar 31, 2020 -115.85 Mn
Dec 31, 2019 1.12 Bn
Sep 30, 2019 884.51 Mn
Mar 31, 2019 -339.22 Mn
Dec 31, 2018 1.20 Bn
Sep 30, 2018 736.73 Mn
Jun 30, 2018 781.56 Mn
Mar 31, 2018 34.33 Mn
Dec 31, 2017 1.06 Bn
Jun 30, 2017 825.49 Mn
Mar 31, 2017 156.72 Mn
Dec 31, 2016 969.15 Mn
Sep 30, 2016 1.01 Bn